• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC 40 REFOBACIN BONE CEMENT R-3; ORTHOPAEDIC CEMENT, MEDICATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC 40 REFOBACIN BONE CEMENT R-3; ORTHOPAEDIC CEMENT, MEDICATED Back to Search Results
Catalog Number 4710500394-3
Device Problem Chemical Problem (2893)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/01/2021
Event Type  malfunction  
Manufacturer Narrative
This is a combination product (b)(4).Report source, foreign and health professional - event occurred in (b)(6).List of associated products : item number 405940 item name comp rvs hmrltrl 44std-36std 4std-36std lot # unknown.Item number 405907 item name 25mm compr rvs taper adapt trl lot # unknown.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported by the nurse an optipac 40g was mixed as usual, with all surgical theatre temperatures same as in the past on average 16 degrees.2min after the mixing, the staff tried to press the cement paste out of the nozzle and it was very sticky and only became workable at about 5min.The doctor complained about the cement consistency.The cement paste took about 15-16min to set.No patient health consequences or impact has been reported.
 
Event Description
It was reported by the nurse that an optipac 40g was mixed as usual, with all surgical theatre temperatures same as in the past on average 16 degrees.2 minutes after the mixing, the staff tried to press the cement paste out of the nozzle and it was very sticky and only became workable at about 5 minutes.The doctor complained about the cement consistency.The cement paste took about 15-16 minutes to set.No patient health consequences or impact has been reported.
 
Manufacturer Narrative
(b)(4).This follow-up is to relay additional information.The device manufacturing quality record can't be performed since the batch number was not communicated.6 complaints on cement paste consistency was recorded on the reference from oct 01, 2018 to dec 28, 2021.The complaint history, regarding the batch number, can't be performed as it was not communicated.According to available data, root cause of the event was unable to be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC 40 REFOBACIN BONE CEMENT R-3
Type of Device
ORTHOPAEDIC CEMENT, MEDICATED
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key12688404
MDR Text Key280574688
Report Number3006946279-2021-00185
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeSF
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number4710500394-3
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/01/2021
Initial Date FDA Received10/25/2021
Supplement Dates Manufacturer Received12/08/2021
Supplement Dates FDA Received01/03/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-